The International Prognostic Scoring System for Waldenström's macroglobulinemia is applicable in patients treated with rituximab-based regimens

Citation:

Dimopoulos MA, Kastritis E, Delimpassi S, Zomas A, Kyrtsonis MC, Zervas K. The International Prognostic Scoring System for Waldenström's macroglobulinemia is applicable in patients treated with rituximab-based regimens. Haematologica [Internet]. 2008;93(9):1420 - 1422.

Notes:

Cited By :29Export Date: 21 February 2017

Website